BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 29656584)

  • 21. Diffusion-weighted imaging in oral squamous cell carcinoma using 3 Tesla MRI: is there a chance for preoperative discrimination between benign and malignant lymph nodes in daily clinical routine?
    Wendl CM; Müller S; Eiglsperger J; Fellner C; Jung EM; Meier JK
    Acta Radiol; 2016 Aug; 57(8):939-46. PubMed ID: 26454065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
    Afaq A; Fraioli F; Sidhu H; Wan S; Punwani S; Chen SH; Akin O; Linch D; Ardeshna K; Lambert J; Miles K; Groves A; Kayani I
    Clin Nucl Med; 2017 Jan; 42(1):e1-e7. PubMed ID: 27607161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of whole-body MRI with diffusion-weighted imaging and PET/CT in lymphoma staging.
    Kharuzhyk S; Zhavrid E; Dziuban A; Sukolinskaja E; Kalenik O
    Eur Radiol; 2020 Jul; 30(7):3915-3923. PubMed ID: 32103366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer.
    Xue HD; Li S; Sun F; Sun HY; Jin ZY; Yang JX; Yu M
    Chin Med Sci J; 2008 Sep; 23(3):133-7. PubMed ID: 18853846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body magnetic resonance imaging in paediatric Hodgkin lymphoma - evaluation of quantitative magnetic resonance metrics for nodal staging.
    Latifoltojar A; Humphries PD; Menezes LJ; Haroon A; Daw S; Shankar A; Punwani S
    Pediatr Radiol; 2019 Sep; 49(10):1285-1298. PubMed ID: 31332480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
    Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
    Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.
    Baranska D; Matera K; Podgorski M; Gorska-Chrzastek M; Krajewska K; Trelinska J; Grzelak P
    MAGMA; 2019 Jun; 32(3):381-390. PubMed ID: 30498885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
    Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of diffusion-weighted magnetic resonance imaging in discriminating between metastatic and non-metastatic pelvic lymph nodes in endometrial cancer.
    Arian A; Easa AM; Arab-Ahmadi M
    Acta Radiol; 2020 Nov; 61(11):1580-1586. PubMed ID: 32106683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
    Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
    J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
    Holzapfel K; Duetsch S; Fauser C; Eiber M; Rummeny EJ; Gaa J
    Eur J Radiol; 2009 Dec; 72(3):381-7. PubMed ID: 18995981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging.
    Eiber M; Beer AJ; Holzapfel K; Tauber R; Ganter C; Weirich G; Krause BJ; Rummeny EJ; Gaa J
    Invest Radiol; 2010 Jan; 45(1):15-23. PubMed ID: 19996762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
    Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
    J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.
    Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J
    J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative evaluation of pelvine lymph node metastasis in high risk prostate cancer with intravoxel incoherent motion (IVIM) MRI.
    Sauer M; Klene C; Kaul M; Quitzke A; Avanesov M; Behzadi C; Budäus L; Beyersdorff D; Adam G; Regier M
    Eur J Radiol; 2018 Oct; 107():1-6. PubMed ID: 30292252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.